Browsing by Author Schwarer, Anthony

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2011Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignanciesBradstock, Kenneth; Chen, Sharon; Sorrell, Tania; Gilroy, N; Halliday, Catriona L.; Morrissey, C. O.; Schwarer, Anthony; Slavin, Monica; Szer, Jeffrey; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteDesign issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies, Leukemia and Lymphoma, vol.52, 2, 2011,pp 179-193
2007Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemiaBradstock, Kenneth; Bardy, Peter; Dodds, A. J.; Durrant, Simon; Goh, Kim; Herrmann, Richard; Ma, David; Moore, John; Nivison-Smith, Ian; Schwarer, Anthony; Szer, Jeff; Western Clinical School: Westmead Millennium InstituteEquivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia, Biology Of Blood And Marrow Transplantation, vol.13,(5),2007,pp 601-607
2013Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trialBradstock, Kenneth; Chen, Sharon; Sorrell, Tania; Bajel, Ashish; Bardy, P G; et al, Various; Gilroy, Nicole M.; Guy, Stephen; Halliday, Catriona; Milliken, Samuel; Moore, John; Morrissey, C. O.; Schwarer, Anthony; Szer, Jeffrey; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteGalactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial, Lancet Infectious Diseases, vol.13, 6, 2013,pp 519-528
2017Idarubicin dose escalation during consolidation therapy for adult acute myeloid leukemiaBenson, Warwick; Bradstock, Kenneth; D'Rozario, James; Di Iulio, Juliana L.; Enno, Arno; et al, Various; Lewis, Ian D.; Link, Emma; Marlton, Paula; Schwarer, Anthony; Szer, Jeff; Wei, Andrew H.; Deans Unit: (CIPHER); Westmead Clinical School: Westmead Institute for Medical ResIdarubicin dose escalation during consolidation therapy for adult acute myeloid leukemia, Journal of Clinical Oncology, vol.35, 15, 2017,pp 1678-1685
2003Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly disgnosed chronic myeloid leukemia in chronic phaseBradstock, Kenneth; Arthur, C.; Branford, Susan; Browett, Peter; Durrant, Simon; Gathmann, I.; Grigg, Andrew P.; Harper, A.; Hughes, T. P.; Joske, D.; Lynch, Kevin; Ma, D.; Rudzki, Zbigniew; Schwarer, Anthony; Seymour, John F.; Taylor, Kerry; Western Clinical School: Westmead Millennium InstituteImatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly disgnosed chronic myeloid leukemia in chronic phase, Leukemia, vol.17,(12),2003,pp 2401-2409
2004Interferon-Alpha-2B And Oral Cytarabine Ocfosfate For Newly Diagnosed Chronic Myeloid Leukaemia.Arthur, Chris; Bradstock, Kenneth; Gibson, John; Browett, Peter; et, al; Grigg, Andrew P.; Hughes, T.; Januszewicz, H.; Mollee, P.; Schwarer, Anthony; Spencer, A.; Wolf, Max; Northern Clinical School: Medicine; Western Clinical School: Westmead Millennium Institute; Central Clinical School: MedicineInterferon-Alpha-2B And Oral Cytarabine Ocfosfate For Newly Diagnosed Chronic Myeloid Leukaemia., Annals of Oncology, vol.15,(12),2004,pp 1810-1815
2008Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantationBradstock, Kenneth; Bardy, Peter B; Danner, Silke; Dean, Melinda M; Doherty, Kathleen; Hahn, Uwe; Heatley, Susan L; Minchinton, Robyn; Mullighan, Charles G; Schwarer, Anthony; Szer, Jeff; Western Clinical School: Westmead Millennium InstituteMannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation, Blood, vol.112, 5, 2008,pp 2120-2128
2006PAMIDRONATE REDUCES BONE LOSS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.Bradstock, Kenneth; Ebeling, Peter R; Grigg, Andrew P.; Herrmann, Richard; Hui, C.; Reynolds, John; Schwarer, Anthony; Shuttleworth, P; Szer, J.; Western Clinical School: Westmead Millennium InstitutePAMIDRONATE REDUCES BONE LOSS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION., The Journal of Clinical Endocrinology & Metabolism (2005), vol.91,(10),2006,pp 3835-3843
2013Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer CellsBradstock, Kenneth; Bardy, P G; et al, Various; Harpur, Christopher; Heatley, Susan; Lester, Susan; Lin, Jie; Pietra, Gabriella; Rossjohn, Jamie; Schwarer, Anthony; Szer, J.; Widjaja, Jacqueline; Western Clinical School: Westmead Millennium InstitutePolymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells, The Journal of Biological Chemistry, vol.288, 12, 2013,pp 8679-8690
2007The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemiaIland, Harry; Campbell, Lynda J.; Catalano, Alberto; Dawson, Mark A.; Opat, Stephen; Schwarer, Anthony; Somana, Karthiga; Central Clinical School: MedicineThe PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia, Blood, vol.110,(12),2007,pp 4073-4076
2014A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemiaBradstock, Kenneth; Collins, Marnie; Cull, Gavin; Di Iulio, Juliana L.; Enno, Arno; Hahn, U; Lewis, Ian D.; Link, Emma; Marlton, P.; Schwarer, Anthony; Seymour, John F.; Szer, Jeff; Western Clinical School: Westmead Millennium InstituteA randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia, British Journal of Haematology, vol.167, 5, 2014,pp 618-625
2004Real-Time Quantitative Pcr Analysis Can Be Used As A Primary Screen To Identify Patients With Cml Treated With Imatinib Who Have Bcr-Abl Kinase Domain Mutations.Bradstock, Kenneth; Branford, Susan; Browett, Peter; Durrant, Simon; et, al; Grigg, Andrew P.; Parkinson, Ian; Rudzki, Zbigniew; Schwarer, Anthony; Seymour, John F.; Taylor, Kerry; Western Clinical School: Westmead Millennium InstituteReal-Time Quantitative Pcr Analysis Can Be Used As A Primary Screen To Identify Patients With Cml Treated With Imatinib Who Have Bcr-Abl Kinase Domain Mutations., Blood, vol.104,(9),2004,pp 2926-2932
2015TIDEL-II: frontline use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsHertzberg, Mark; Taper, John; Trotman, Judith; Braley, Jodi; Branford, Susan; et al, Various; Herschtal, Alan; Hiwase, Devendra K; Issa, Samra; Kornhauser, Michael; Osborn, Michael P; Schwarer, Anthony; White, Deborah L; Yeung, David T; Western Clinical School: Medicine (Westmead); Medicine; Concord Clinical School: MedicineTIDEL-II: frontline use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets, Blood, vol.125, 6, 2015,pp 915-923